Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eileen Scigliano
Bendamustine-Brentuximab: Bridging to Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Bridging Strategies to Allogeneic Transplant for Older AML Patients
Cancers
Cancer Research
Oncology
First Salvage Treatment With Bendamustine and Brentuximab Vedotin in Hodgkin Lymphoma: A Phase 2 Study of Fil Onlus
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Bridging Strategies and Their Association With Post Heart Transplant Outcomes
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Brentuximab Vedotin and Bendamustine as Salvage Therapy for Primary Refractory or Relapsed Hodgkin Lymphoma: A Multicentre Experience of the Polish Lymphoma Research Group
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
High Response Rates and Safe Toxic Profile of Brentuximab Vedotin/Bendamustine Combination in Heavily Pretreated Patients With Relapsed/Refractory Hodgkin Lymphoma (HL)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
High-Dose Bendamustine Plus Brentuximab Combination Is Effective and Has a Favourable Toxicity Profile in the Treatment of Refractory and Relapsed Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Brentuximab-Vedotin and Bendamustine Is a Feasible and Effective Drug Combination as First-Line Treatment of Hodgkin Lymphoma in the Elderly (Halo Trial)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
PSY5 Comparing Brentuximab Vedotin Overall Survival Data to Standard of Care in Patients With Relapsed/Refractory Hodgkin Lymphoma (HL) Post-Autologous Stem Cell Transplant (ASCT)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Hypertriglyceridemia Induced Pancreatitis Due to Brentuximab Therapy: First Case Report
Cureus
